JGC
AGN

J. Goldman & Co’s Allergan plc AGN Stock Holding History

J. Goldman & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-50,300
Closed -$13.5M – 435
2016
Q1 		$13.5M Buy
50,300
+28,129
+127% +$8.05M 0.84% 26
2015
Q4 		$6.93M Buy
22,171
+21,432
+2,900% +$6.38M 0.71% 43
2015
Q3 		$201K Buy
+739
New +$227K 0.02% 193
2015
Q1 		– Sell
-7,342
Closed -$2.09M – 324
2014
Q4 		$1.89M Sell
7,342
-2,588
-26% -$647K 0.22% 121
2014
Q3 		$2.4M Buy
+9,930
New +$2.22M 0.14% 165
2013
Q3 		– Sell
-26,116
Closed -$3.3M – 359
2013
Q2 		$3.3M Buy
+26,116
New +$2.96M 0.34% 100

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

J. Goldman & Co's AGN Position: Q2 2016 in Review

J. Goldman & Co sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 50,300 shares — an estimated $13.5M sold.

J. Goldman & Co first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $13.5M in Q1 2016. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • J. Goldman & Co reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • J. Goldman & Co sold 50,300 Allergan plc shares in Q2 2016, an estimated $13.5M.
  • J. Goldman & Co first reported a position in Allergan plc in Q2 2013 and held it in 6 quarters.
  • J. Goldman & Co's Allergan plc position peaked at $13.5M in Q1 2016.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on J. Goldman & Co's 13F filing for Q2 2016, filed 15 Aug 2016.